# Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic Wounds

> **NCT05764226** · NA · COMPLETED · sponsor: **Nakhia Impex LLC** · enrollment: 20 (actual)

## Conditions studied

- Chronic Wounds

## Interventions

- **DRUG:** HA35(L20200708MP07707, Ministry of Health, Mongolia)was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)

## Key facts

- **NCT ID:** NCT05764226
- **Lead sponsor:** Nakhia Impex LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-06
- **Primary completion:** 2022-12-29
- **Final completion:** 2023-02-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-03-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05764226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05764226, "Freshly Manufactured 35kDa Hyaluronan Fragment HA35 for the Treatment of Chronic Wounds". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05764226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*